The next big market for weight-loss drugs: children

The next big market for weight-loss drugs: children

Thomson Reuters

Danish drugmaker Novo Nordisk's weight loss drug Saxenda has helped children aged six to 11 reduce their body mass index, according to trial results released on Tuesday.

No comments

Read more